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Abstract
Background: Personality traits may form a part of the aetiology of opioid dependence. For
instance, opioid dependence may result from self-medication in emotionally unstable individuals, or
from experimenting with drugs in sensation seekers. The five factor model (FFM) has obtained a
central position in contemporary personality trait theory. The five factors are: Neuroticism,
Extraversion, Openness to Experience, Agreeableness and Conscientiousness. Few studies have
examined whether there is a distinct personality pattern associated with opioid dependence.
Methods: We compared FFM personality traits in 65 opioid dependent persons (mean age 27
years, 34% females) in outpatient counselling after a minimum of 5 weeks in buprenorphine
replacement therapy, with those in a non-clinical, age- and sex-matched sample selected from a
national database. Personality traits were assessed by a Norwegian version of the Revised NEO
Personality Inventory (NEO PI-R), a 240-item self-report questionnaire. Cohen's d effect sizes were
calculated for the differences in personality trait scores.
Results: The opioid-dependent sample scored higher on Neuroticism, lower on Extraversion and
lower on Conscientiousness (d = -1.7, 1.2 and 1.7, respectively) than the controls. Effects sizes
were small for the difference between the groups in Openness to experience scores and
Agreeableness scores.
Conclusion: We found differences of medium and large effect sizes between the opioid dependent
group and the matched comparison group, suggesting that the personality traits of people with
opioid dependence are in fact different from those of non-clinical peers.
Background
Opioid dependence is a severe condition associated with
substantial psychological, social and medical impair-
ment, as well as poor treatment outcomes. The aetiology
of opioid dependence is not quite established. We believe
a number of aspects are involved, including biological,
psychological and socioeconomic factors [1,2].
According to the self-medication hypothesis [3-5], emo-
tionally unstable individuals may experience that their
psychological distress is alleviated when they use opioids.
In that respect, using opioids can be seen as a response in
a negative reinforcement process [6,7] – it removes an
aversive stimulus (psychological distress), reinforcing the
response (increased tendency to use opioids).
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Opioid use has also been associated with sensation seek-
ing and engagement in risk behaviours [8-10]. Zuckerman
views sensation seeking as a personality trait with biolog-
ical foundations, making some people more inclined to
engage in risk behaviours than others [11].
The five-factor model (FFM) [12,13] of personality is a
conceptualisation of personality comprising behavioural,
emotional and cognitive patterns. These patterns are
thought of as enduring dispositions which have proved to
be stable from the age of 30 [14,15]. Also, the FFM has
been reproduced in a number of culturally different coun-
tries [16-18], indicating a universally valid structure. The
FFM has a hierarchical structure; each of the five domains
Neuroticism, Extraversion, Openness to experience,
Agreeableness and Conscientiousness is defined by six
subdomains, or facets.
Studies of relationships between FFM dimensions and
mental health indicate that people with psychiatric disor-
ders have distinct personality patterns [19-22]. One meta-
analysis found a general pattern of high Neuroticism, low
Conscientiousness, low Agreeableness and low Extraver-
sion in people with clinical symptoms [20]. Another
meta-analysis identified high Neuroticism and low Agree-
ableness as underlying dimensions of most personality
disorders [21]. People with various substance use disor-
ders also seem to have a common personality profile: high
Neuroticism, low Conscientiousness and low Agreeable-
ness [23-29].
Two US studies have examined FFM personality traits in
people with opioid dependence. Personality patterns were
consistent with those of people with psychiatric and of
people with substance use disorders, i.e. high Neuroti-
cism, low Conscientiousness and low Agreeableness
[30,31]. At the subdomain level, the largest deviations
from norm scores were seen in Neuroticism facets Depres-
sion and Vulnerability, Agreeableness facets Trust and
Straightforwardness, and Conscientiousness facets Com-
petence, Dutifulness, Achievement Striving and Self-Disci-
pline.
To these authors' knowledge there are no studies on the
relationships between FFM personality traits and opioid
dependence conducted outside the USA. Studies from
other countries are needed to supplement US studies and
the understanding of the origins and consequences of
dependent opioid use. The aim of this study was to exam-
ine whether there is a distinct personality pattern associ-
ated with opioid dependence in young Norwegian adults,




The opioid dependent sample was 65 participants in a fea-
sibility trial of short-term buprenorphine replacement
therapy in 2002–2003 [32,33]. Inclusion criteria in the
feasibility trial were: age ≥ 22 years, opioid dependence
diagnosed with the Composite International Diagnostic
Interview [34], and enrolled in one of five specific outpa-
tient clinics in South Eastern Norway. Persons with severe
medical or psychiatric conditions or who had a prison
sentence pending were excluded because they would be
unable to adhere to the study protocol.
The sample's mean age was 26.8 years (SD 3.4; range 22–
39), and 34% and 66% were women and men, respec-
tively. Seven participants (11%) had more than 12 years'
education and 18 (28%) were living with a partner.
Thirty-nine participants (60%) had a lifetime mood disor-
der, 46 (70%) had an anxiety disorder and 52 (80%) had
a personality disorder. Twenty-eight participants (43%)
had spent more than 14 consecutive days in prison or cus-
tody. A majority of participants had used a number of
illicit substances the last 30 days prior to intake to the fea-
sibility trial (Table 1).
A minimum of 5 weeks after buprenorphine induction,
when assumed to have achieved a stable state, patients
were requested to complete the NEO-PI-R at the clinics.
Instructions were given both verbally and in writing, and
clinic staff was available for answering any questions
regarding the inventory. Approvals were granted from the
Regional Committee for Medical Research Ethics, Norwe-
gian Medicines Agency and the Data Inspectorate. All par-
ticipants were informed both orally and in writing about
the study, and signed informed consent forms.
Matched comparison group
For each opioid dependent participant a comparison per-
son with matching age and sex was randomly drawn from
a national data base containing scores of 1153 individuals
representing a wide range of the general Norwegian pop-
ulation. Individuals with known psychiatric disorder were
removed from the database. Data from the comparison
Table 1: Illicit substance use last 30 days prior to intake to trial 






Heavy drinking 10 (15)
Poly-substance use 51 (78)
Injecting use 51 (78)BMC Psychiatry 2007, 7:37 http://www.biomedcentral.com/1471-244X/7/37
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group were collected consecutively in various settings over
a number of years (1998–2001). Thirty-two (49%) were
graduate students and 20 (31%) were professionals. For
the remaining comparison group we only know that 10
(15%) were participants in studies of physical activity or
monozygotic twins.
Analyses
The Norwegian version of the NEO-PI-R [35] was used for
FFM personality trait assessments. Each individual's T-
scores (mean = 50, SD = 10) were calculated on the basis
of national combined norms.
Analyses were conducted using the statistical package
SPSS for Windows, version 11.0 [36]. Cohen's d effect
sizes [37] were calculated for the differences in T-scores
between opioid dependent subjects and controls. Statisti-
cal power calculations showed that the sample size
allowed the detection of a difference of a medium effect
size (d ≥ 0.50) at the 0.01-level with power > 0.8.
Results
The non-clinical comparison group did not have any
mean scores that deviated more than 2 points from the
general norm mean (Table 2).
In the opioid dependent sample there were several devia-
tions with medium (d ≥ 0.50) or large (d ≥ 0.80) effect
sizes from the comparison group mean scores (Table 2):
￿ higher scores on Neuroticism and facets Anxiety, Angry
Hostility, Depression, Self-Consciousness and Vulnerabil-
ity
￿ lower scores on Conscientiousness and all facets
￿ lower scores on Extraversion and facets Warmth, Gregar-
iousness, Assertiveness, Activity and Positive Emotions.
Moreover, the opioid dependent sample had lower scores
on Agreeableness facets Trust and Straightforwardness.
There were no medium or large effect sizes for any of the
differences in Openness to Experience facets, except for
Openness to Values (d = 0.51).
Almost half the opioid dependent sample (29; 45%)
scored above the comparison sample's 95th percentile on
Neuroticism (T-score ≥ 63.95). Corresponding frequen-
cies of extreme scorers (below the 5th percentile) were
26%, 19%, 3% and 2% for Conscientiousness (T-score ≤
29.93), Extraversion (T-score ≤ 33.11), Openness to Expe-
rience (T-score ≤ 31.18) and Agreeableness (T-score ≤
28.44), respectively. When the 75th and 25th percentiles
were used as cut-offs for extreme scorers, the frequencies
were 88% for Neuroticism (T-score ≥ 55.67), 83% for
Conscientiousness (T-score ≤ 45.12), 72% for Extraver-
sion (T-score ≤ 46.99), 43% for Agreeableness (T-score ≤
44.02) and 29% for Openness to Experience (T-score ≤
42.05).
Discussion
The Norwegian opioid dependent sample resembled the
US ones [30,31] in terms of high Neuroticism, low Con-
scientiousness and average Openness to Experience. There
were also dissimilarities between Norwegian and US find-
ings: low Extraversion in Norwegian opioid users and no
difference in Agreeableness between the opioid depend-
ent and the comparison group.
Both this and the US studies of opioid dependent samples
confirmed other research observations of high Neuroti-
cism and low Conscientiousness in substance use disor-
ders, across nationalities, sample age (US samples were
older than the Norwegian one) and type of substances
used (US participants were frequently co-dependent on
cocaine). High Neuroticism in people with substance
dependence can be seen as consistent with the self-medi-
cation hypothesis: people use and become dependent on
opioids because they are emotionally unstable. However,
we do not yet know the direction of causality, or whether
one causes the other at all. Low Conscientiousness may be
a common denominator for opioid use, risk behaviours
and sensation seeking. Opioid users appear to share the
low levels of Conscientiousness with people with risky
health behaviours [30,38-41], and risk behaviours have
been associated with sensation seeking [11].
The lack of differences between the two groups in Open-
ness to Experience was also supportive of earlier work,
suggesting that a person's degree of conventionality and
adherence to traditions is unrelated to opioid depend-
ence.
It is difficult to explain the low Extraversion in Norwegian
opioid users. One approach is to see the high prevalence
of psychiatric disorders in this sample in relation to previ-
ous studies showing strong associations between pure
mood, anxiety or psychotic disorders and low Extraver-
sion [20]. More knowledge about the mental health state
in the US opioid dependent samples would of course shed
light to such an approach.
Despite a lacking relationship between opioid depend-
ence and Agreeableness at the domain level we found
deviations that were consistent with US findings at the
facet level. People with opioid dependence seem to be less
trusting and less straightforward than the norm in both
countries. Further, we calculated Cohen's d for Agreeable-
ness in one of the US samples [31], which was 0.7, i.e.
medium effect size. The correspondent Norwegian d wasBMC Psychiatry 2007, 7:37 http://www.biomedcentral.com/1471-244X/7/37
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Table 2: Domain and facet level T-scores for opioid dependent sample and comparison sample
Opioid dependent sample (N = 65) Comparison sample (N = 65)
Mean SD Mean SD d 95% confidence interval
DOMAIN LEVEL
NEUROTICISM * 64 8.0 49 8.9 1.74 1.3–2.14
EXTRAVERSION 41 8.4 51 8.9 1.17 0.80–1.54
OPENNESS TO EXPERIENCE 48 9.5 52 12.4 0.35 0.00–.69
AGREEABLENESS 46 8.3 51 11.0 0.49 0.14–.83
CONSCIENTIOUSNESS 36 8.1 50 9.3 1.67 1.27–2.07
Neuroticism facets
Anxiety* 61 8.4 49 9.0 1.38 1.00–1.76
Angry hostility* 58 9.4 49 10.4 0.91 0.56–1.27
Depression* 65 7.0 49 8.9 2.02 1.59–2.44
Self-consciousness* 62 8.7 50 9.3 1.32 0.94–1.69
Impulsiveness* 54 8.3 52 10.1 0.29 0.00–0.63
Vulnerability* 63 9.6 49 8.6 1.54 1.15–-1.93
Extraversion facets
Warmth 41 9.6 50 11.1 0.87 0.51–1.23
Gregariousness 41 10.6 50 10.4 0.89 0.52–1.25
Assertiveness 42 8.0 49 8.9 0.94 0.58–1.30
Activity 43 9.0 50 8.4 0.72 0.37–1.08
Excitement seeking* 54 7.9 52 10.0 -0.28 0.00–0.62
Positive emotions 40 7.7 53 9.0 1.57 1.17–1.96
Openness to Experience facets
Fantasy 48 8.9 53 10.7 0.48 0.13–0.83
Aesthetics* 51 9.7 50 12.1 -0.11 0.00–0.44
Feelings 49 9.2 53 11.4 0.36 0.01–0.71
Actions* 49 8.2 48 10.0 -0.08 0.00–0.40
Ideas 47 10.6 52 11.7 0.45 0.10–0.79
Values 47 7.7 52 11.4 0.51 0.16–0.86
Agreeableness facets
Trust 39 11.3 52 11.2 1.11 0.74–1.48
Straightforwardness 45 10.1 50 9.9 0.53 0.18–0.88
Altruism 47 9.3 50 12.0 0.31 0.04–0.65
Compliance 46 9.4 49 10.2 0.21 0.14–0.55
Modesty* 54 8.3 50 10.7 -0.47 0.15–0.81
Tender-mindedness* 53 8.5 52 12.1 -0.01 0.00–0.07
Conscientiousness facets
Competence 35 10.9 52 10.1 1.53 1.14–1.92
Order 44 7.0 50 10.5 0.68 0.32–1.03
Dutifulness 38 8.5 51 9.4 1.47 1.08–1.86
Achievement striving 42 11.3 51 9.1 0.94 0.57–1.30
Self-discipline 38 7.8 50 9.6 1.36 0.97–1.74
Deliberation 39 7.5 48 10.8 0.97 0.61–1.34
* Negative d valuesBMC Psychiatry 2007, 7:37 http://www.biomedcentral.com/1471-244X/7/37
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0.49, i.e. approaching medium effect size. The apparent
deviation in the Norwegian and US findings regarding
Agreeableness may be a statistical artefact related to sam-
ple size. Further, while high Neuroticism and low Consci-
entiousness are consistent elements in substance use
disorder personality profiles across studies [23,25-29],
there are examples of studies where low Agreeableness
failed to emerge [24,26,28], indicating a weaker associa-
tion.
A limitation of this study is that we do not know to what
extent participants were under the influence of illicit drugs
when completing the personality inventory. In Carter and
colleagues' study, all participants tested positive for illicit
opioids or other drugs at the first administration of the
NEO-PI-R, and 75% were using illicit substances during
the second administration [31]. We did not administer
the NEO-PI-R until the sixth week of buprenorphine
replacement therapy, when patients were assumed to have
achieved stability with regard to substance use. Data from
the feasibility trial show that this assumption was rather
reasonable. Assessments 3 months after the first
buprenorphine dose showed that substance use was mod-
est and significantly reduced since inclusion assessments
[32].
There is also a possibility that both buprenorphine
replacement therapy and counselling may have influ-
enced the opioid dependent participants' personality trait
scores. In that case we would expect even higher Neuroti-
cism and lower Conscientiousness at intake to the feasi-
bility trial and even more homogeneity in terms of high
frequencies of extreme scores. Piedmont and colleagues
found persisting changes in Neuroticism, Conscientious-
ness and Agreeableness in a sample with substance use
disorders after a 6-week counselling programme [42].
Further, our study design can only identify associations
with unknown causal directions. On one hand, the opioid
dependent sample's distinct personality profile could be
understood as part of the aetiology of opioid dependence.
Several investigations have documented that personality
traits are remarkably stable [14,15,43], that they have a
significant hereditary component [44], and that they have
behavioural implications, i.e., they influence behavior in
any situation and they contribute to decisions on which
situations individuals are motivated to enter and partici-
pate in [45]. On the other hand, the opioid-dependent
sample's personality profile could be explained by a
shared, distinctive lifestyle associated with long-term sub-
stance use. There is evidence suggesting that personality
traits are less stable in younger adults than older adults
[46], and thus more susceptible to external influences.
The five-factor model of personality has obtained a central
position in contemporary personality trait theory. The
impact of group personality profiles have been examined
in several fields, including occupational psychology and
mental health. Merely describing the personality charac-
teristics of individuals with opioid dependence is not
enough. We need to know more about how personality
traits influence prognosis. It could also be useful to model
treatment programmes using knowledge of the group's
typical personality profile, and evaluating the effective-
ness of such programmes compared to standard treat-
ment.
Conclusion
Patients with opioid dependence were more emotionally
unstable, more introverted and less structured than the
non-clinical controls. These findings may represent risk
factors for opioid dependence, but may also be results of
the lifestyles of illicit substance users. Nevertheless, the
distinct personality profiles of opioid dependent patients
may have implications for choice of therapeutic approach.
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